An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD)
Phase 2 study testing votoplam in Huntington's disease.
Active, not recruitingPhase 2DrugClinicalTrials.govTreatment trial
Recruiting in: Angers, Barakaldo, Barcelona +21 more (Australia, Austria, Canada +7 more)
Sponsor: Novartis Pharmaceuticals
Preparing a short plain-English summary.